Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

16.54
Delayed Data
As of Nov 22
 +0.55 / +3.44%
Today’s Change
8.31
Today|||52-Week Range
18.65
+13.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-462.3M629.0M-41.7M1.4B
 
 
 
 
 
Depreciation649.1M674.0M656.4M799.9M
 
 
 
 
 
Total Other Cash Flow262.4M-25.0M-144.7M229.2M
 
 
 
 
 
Funds From Operations530.4M324.0M226.6M497.3M
 
 
 
 
 
Funds From/For Other Operating Expenses58.1M-592.0M-31.1M-77.0M
 
 
 
 
 
Net Cash Flow - Operating Activities472.4M916.0M257.7M574.3M
 
 
 
 
 
 
InvestingIncrease In Investments431.2K0.00-992.1K-3.2M
 
 
 
 
Decrease In Investments95.8K0.00992.1K1.1M
 
 
 
 
Capital Expenditures-50.8M-38.0M-36.4M-48.9M
 
 
 
 
 
Fixed Asset Disposal63.9M1.3B810.1M1.1B
 
 
 
 
 
Net Assets From Acquisitions 30.7M-9.0M9.0M0.00
 
 
 
 
Other Investing - Uses-29.8M0.000.000.00
 
 
Net Cash Flow Investing9.5M1.1B773.8M1.0B
 
 
 
 
 
 
FinancingShort Term Borrowings3.1M-1.0M-5.9M-1.4M
 
 
 
 
 
Long Term Borrowings-20.9M6.2B-51.1M327.2M
 
 
 
 
 
Long Term Debt Reduction-488.9M-7.6B-158.3M-1.9B
 
 
 
 
 
Net Proceeds Stock Sale-669.6K0.000.000.00
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----------
Other Uses - Financing39.7M9.0M28.7M20.8M
 
 
 
 
 
Net Cash Flow - Financing-538.7M-1.4B-244.0M-1.6B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-60.1M8.0M15.8M16.9M
 
 
 
 
 
 
Net Change In Cash-56.7M660.0M787.5M2.7M